Neuropathic pain is caused by a lesion or disease of the somatosensory system, including
peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7–10% of the …

Injury to or disease of the nervous system can invoke chronic and sometimes intractable
neuropathic pain. Many parallel, interdependent, and time-dependent processes, including …

Patients with neuropathic pain are heterogeneous in etiology, pathophysiology, and clinical
appearance. They exhibit a variety of painrelated sensory symptoms and signs (sensory …

Neuropathic pain (NeP) can result from sources as varied as nerve compression,
channelopathies, autoimmune disease, and incision. By identifying the neurobiological …

Neuropathic pain—pain caused by a lesion or disease of the somatosensory nervous
system—is underdiagnosed and difficult to treat. However, development of easy-to-use …

In a recent cluster analysis, it has been shown that patients with peripheral neuropathic pain
can be grouped into 3 sensory phenotypes based on quantitative sensory testing profiles …

We provide an up-to-date review of the pharmacological treatment of neuropathic pain with
emphasis on the latest evidence-based recommendations for its pharmacological treatment …

Introduction: Neuropathic pain affects up to 8% of the population with few therapeutic
options for its management. No specific drugs are approved for its treatment. Areas covered …

The personalization of neuropathic pain treatment could be improved by identifying specific
sensory phenotypes (ie, specific combinations of symptoms and signs) predictive of the …

Neuropathic pain remains poorly treated for large numbers of patients, and little progress
has been made in developing novel classes of analgesics. To redress this issue, ziconotide …